Regulation of Glial Cell Functions by PPAR‐γ Natural and Synthetic Agonists
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
In the recent years, the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), a well known target for type II diabetes treatment, has received an increasing attention for its therapeutic potential in inflammatory and degenerative brain disorders. PPAR‐γ agonists, which include naturally occurring compounds (such as long chain fatty acids and the cyclopentenone prostaglandin 15‐deoxy Δ12,14 prostaglandin J 2), and synthetic agonists (among which the thiazolidinediones and few nonsteroidal anti‐inflammatory drugs) have shown anti‐inflammatory and protective effects in several experimental models of Alzheimer′s and Parkinson′s diseases, amyotrophic lateral sclerosis, multiple sclerosis and stroke, as well as in few clinical studies. The pleiotropic effects of PPAR‐γ agonists are likely to be mediated by several mechanisms involving anti‐inflammatory activities on peripheral immune cells (macrophages and lymphocytes), as well as direct effects on neural cells including cerebral vascular endothelial cells, neurons, and glia. In the present article, we will review the recent findings supporting a major role for PPAR‐γ agonists in controlling neuroinflammation and neurodegeneration through their activities on glial cells, with a particular emphasis on microglial cells as major macrophage population of the brain parenchyma and main actors in brain inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 2×
“In addition, activated microglia can synthesize a range of different molecules, including free radicals, inflammatory cytokines, chemokines, lipid mediators, and neurotrophic factors, whose typical profile will determine the outcome of microglial activation in term of repair or injury [70].”
BackgroundDormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · cited 2×
“In addition, astrocytes exert important roles also in brain inflammation and immunity, as they express several— though fewer than microglia—pattern-recognition receptors (PRRs) such as for example the Toll-like receptors, and release cytokines and chemokines that can trigger or amplify the local inflammatory response…”
BackgroundSystemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027 · cited 1×
“Importantly, the different states of activation can be switched between one state and another during the course of disease or in response to further stimuli or signals from the periphery [72].”
BackgroundSelective Vulnerability of Late Oligodendrocyte Progenitors to Hypoxia–Ischemia
Back, S. A., Han, B. H., Luo, N. L., Chricton, C. A., Xanthoudakis, S., Tam, J., Arvin, K. L., & Holtzman, D. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00455.2002 · Cited by 795 · cited 1×
“(a) Immunocytochemistry of rat OL progenitor cultures, prepared as previously described [40] for PPAR-γ (upper panel)”
MethodRisner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
Peroxisome proliferator-activated receptors: insight into multiple cellular functions
Escher, P., & Wahli, W. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00231-6 · Cited by 491 · cited 2×
“At protein level, all three PPARs show a similar organization in five different functional domains, two of which— the DNA-binding domain (DBD) and the ligand-binding domain (LBD)—are the highly conserved [2].”
BackgroundCombs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00558.2000 · Cited by 483
Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes
Kassmann, C. M., Lappe-Siefke, C., Baes, M., Brügger, B., Mildner, A., Werner, H. B., Natt, O., Michaelis, T., Prinz, M., Frahm, J., et al. (2007) · Nature Genetics · doi:10.1038/ng2070 · Cited by 357 · cited 7×
“The maturation of pre-OLs was accompanied by enhanced expression of alkyl-dihydroxyacetone phosphate synthase (ADAPS), a peroxisomal enzyme required for the synthesis of plasmalogen, an etherphospholipid essential for myelin formation.”
BackgroundInfluentialReceptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
Feinstein, D. L., Spagnolo, A., Akar, C., Weinberg, G., Murphy, P., Gavrilyuk, V., & Russo, C. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.033 · Cited by 275
Bernardo, A., Levi, G., & Minghetti, L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00110.x · Cited by 222
Self-citationPark, E. J., Park, S. Y., Joe, E.-H., & Jou, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210819200 · Cited by 214 · cited 1×
“…15d-PGJ2 was prevented by preincubation of cell cultures with N-acetyl cysteine, a reducing agent and a precursor molecule for glutathione (GSH) synthesis, but not with free radical scavengers, the authors suggest that the underlying mechanism is related to oxidative stress due to depletion of GSH.”
BackgroundS., P. A. (2006) · doi:10.4049/jimmunol.176.7.4385 · Cited by 80 · cited 1×
“…15d-PGJ2 was prevented by preincubation of cell cultures with N-acetyl cysteine, a reducing agent and a precursor molecule for glutathione (GSH) synthesis, but not with free radical scavengers, the authors suggest that the underlying mechanism is related to oxidative stress due to depletion of GSH.”
BackgroundBernardo, A., Ajmone‐Cat, M. A., Levi, G., & Minghetti, L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02045.x · Cited by 45
Self-citation
Cited by
Microglial Activation in Stroke: Therapeutic Targets
Yenari, M. A., Kauppinen, T. M., & Swanson, R. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.005 · Cited by 389
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation
Villapol, S. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0554-5 · Cited by 369
PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
Corona, J. C., & Duchen, M. R. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.023 · Cited by 259
Jamwal, S., Blackburn, J. K., & Elsworth, J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107705 · Cited by 236
“Within the CNS, PPARγ is present in several cell types including neurons, astrocytes, oligodendrocytes and microglia (Bernardo & Minghetti, 2008; Corona & Duchen, 2015, Pharmacol Ther.”
BackgroundPPAR‐gamma‐mediated neuroprotection in a chronic mouse model of Parkinson’s disease
Schintu, N., Frau, L., Ibba, M., Caboni, P., Garau, A., Carboni, E., & Carta, A. R. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06657.x · Cited by 200
“Peroxisome proliferator-activated receptor-gamma (PPAR-c) is a member of the nuclear receptor family that regulates lipid and carbohydrate homeostasis, and exerts antiinflammatory actions both in the periphery and CNS (Heneka et al., 2007; Bernardo & Minghetti, 2008).”
Background
Metadata
- Authors
- Bernardo, A., & Minghetti, L.
- Venue
- PPAR Research
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 2008
- Issue
- 1
- Pages
- 864140-864140
- ISSN
- 1687-4757 (ISSN-L)
- 1687-4765
- OpenAlex
- W2008938471
- Cited by
- 119
- References
- 15
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.